✦ LIBER ✦

The Future of Drug Development and Therapy in Myeloma

✍ Scribed by Lonial, Sagar; Boise, Lawrence H.

Book ID: 122294877
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 113 KB
Volume: 40
Category: Article
ISSN: 0093-7754
DOI: 10.1053/j.seminoncol.2013.07.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Future drug developments in multiple mye

Future drug developments in multiple myeloma: an overview of novel lenalidomide-based combination therapies

✍ Gareth Morgan 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 214 KB

The introduction of thalidomide, lenalidomide, and bortezomib has changed the way that multiple myeloma (MM) is treated and has greatly improved survival outcomes. These novel agents are often used in combination with conventional drugs, such as dexamethasone, to optimize clinical responses; however

New drugs and future developments in pho

New drugs and future developments in photodynamic therapy

✍ Ash, D.V.; Brown, S.B. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 466 KB

Drug resistance and drug development in

Drug resistance and drug development in multiple myeloma

✍ William S. Dalton 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 277 KB

THE FUTURE OF DRUG THERAPY

✍ Dixon, W.E. 📂 Article 📅 1923 🏛 The Lancet 🌐 English ⚖ 429 KB

State of the art therapy in multiple mye

State of the art therapy in multiple myeloma and future perspectives

✍ Ulrich Denz; Peter S. Haas; Ralph Wäsch; Hermann Einsele; Monika Engelhardt 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 296 KB

Future Directions of Next-Generation Nov

Future Directions of Next-Generation Novel Therapies, Combination Approaches, and the Development of Personalized Medicine in Myeloma

✍ Mitsiades, C. S.; Davies, F. E.; Laubach, J. P.; Joshua, D.; Miguel, J. S.; Ande 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 111 KB